Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 5 (2018) Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA Abstract  similar documents
Bayer Company Press Release
"... антикоагулянта ривароксабана в дозе 2,5 мг 2 р/д в сочетании с 75-100 мг ацетилсалициловой кислоты один раз в ..."
 
Vol 12, No 4 (2016) Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation Abstract  similar documents
S. G. Kanorskii
"... In XANTUS study the safety and efficacy of factor Xa inhibitor rivaroxaban were evaluated ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... Aim. To study the effect of rivaroxaban compared with warfarin on the incidence of cardioembolic ..."
 
Vol 15, No 4 (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... results demonstrate a favorable efficiency and safety profile of rivaroxaban in comparison with warfarin ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
"... . The alternative antithrombotic agents, including rivaroxaban presented along with the traditional drugs (acetyl ..."
 
Vol 12, No 2 (2016) THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE Abstract  similar documents
S. V. Moiseev
"... New oral anticoagulants that inhibit factor Xa (rivaroxaban, apixaban, edoksaban) or thrombin ..."
 
Vol 10, No 3 (2014) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... attractive, is rivaroxaban. ..."
 
Vol 11, No 5 (2015) New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation Abstract  similar documents
article Editorial
"... rivaroxaban in patients with non-valvular atrial fibrillation  ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... ) on rivaroxaban therapy are presented. Good efficacy and  safety  of full and  reduced doses  of rivaroxaban were ..."
 
Vol 14, No 4 (2018) Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice Abstract  similar documents
N. M. Vorobyeva, O. N. kacheva
"... The possibility of rivaroxaban using in elderly patients with non-valvular atrial fibrillation ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... and rivaroxaban). Aim. To assess the influence of apixaban use on the budget as an alternative to warfarin ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... . Along with traditional drugs (acetylsalicylic acid, warfarin) rivaroxaban is specially considered ..."
 
Vol 15, No 2 (2019) Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova
"... for two RCTs with rivaroxaban - EINSTEIN-DVT and EINSTEIN-PE) contained data on the participation of frail ..."
 
Vol 13, No 1 (2017) DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT Abstract  similar documents
D. А. Napalkov, A. A. Sokolova, V. V. Fomin
"... was previously demonstrated in ARISTOTLE trial. On the contrary, rivaroxaban was associated with the most ..."
 
Vol 13, No 2 (2017) RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY Abstract  similar documents
. Editorial
"... обеих группах пациентов, получавших ривароксабан, результаты лечения оказались лучше в отношении ..."
 
Vol 12, No 3 (2016) THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT Abstract  PDF (Eng)  similar documents
S. R. Gilyarevskiy
"... the validity of monotherapy tactics with rivaroxaban in patients with VTE. The results of this study ..."
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... dabigatran, rivaroxaban and apixaban) is presented from the standpoint of safety. The safety profile ..."
 
Vol 9, No 4 (2013) COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS Abstract  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
"... Варфарин ОШ (95% ДИ) Пациенты События Число событий Пациенты События Число событий на 100 на 100 пациенто ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... исследовании принима- ли участие 14 264 пациента с ФП. Результаты иссле- дования показали, что ривароксабан в ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... медицинской этики. Ключевые слова: фибрилляция предсердий, дабигатран, апиксабан, ривароксабан, риск ..."
 
Vol 12, No 1 (2016) Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita Abstract  similar documents
S. N. Bel'diev
"... Currently there are no generally accepted guidelines for the use of rivaroxaban together ..."
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... Aim. To compare cost-effectiveness of the use of direct factor Xa inhibitors rivaroxaban ..."
 
Vol 13, No 5 (2017) DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov
"... The opinion is expressed in some  domestic publications that  rivaroxaban has  the  most ..."
 
Vol 10, No 2 (2014) RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL Abstract  similar documents
J. L. Mega, E. Braunwald, S. A. Murphy, A. N. Plotnikov, P. Burton, R. G. Kiss, A. Parkhomenko, M. Tendera, P. Widimsky, C. M. Gibson
"... Цель. Представлен анализ лечения ривароксабаном в заранее определенной подгруппе больных инфарктом ..."
 
Vol 13, No 3 (2017) PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION Abstract  similar documents
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko
"... of genotype on rivaroxaban pharmacokinetics in the study involving the carriers of ABCB1 gene rs2032582 and rs ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
"... - следования ROCKET AF, где сравнивали эффектив- ность и безопасность ривароксабана и варфарина [49]. Пациенты ..."
 
Vol 15, No 3 (2019) Treatment of Patients with Stable Manifestations of Atherosclerosis: New Opportunities Abstract  similar documents
article Editorial
"... of both coagulation and platelet). Experts noted that combination of rivaroxaban 2.5 mg BID ..."
 
Vol 12, No 6 (2016) NEW DATA OF EXTENSIVE RESEARCH PROGRAM AND THE RESULTS OF STUDIES IN REAL CLINICAL PRACTICE FROM DIFFERENT COUNTRIES REAFFIRMED THE HIGH EFFICACY AND A FAVORABLE SAFETY PROFILE OF RIVAROXABAN (XARELTO®) FROM THE BAYER COMPANY PRESS RELEASE OF THE BAYER COMPANY Abstract  similar documents
article editorial
"... перорального ингибитора Xa фактора Ксарелто® (ривароксабана) у пациентов с неклапанной фибрилляцией предсердий ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... , rivaroxaban and dabigatran. Along with clinical efficacy and safety profile one of the main characteristics ..."
 
Vol 13, No 6 (2017) PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS Abstract  similar documents
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin
"... – rivaroxaban and apixaban) were included into the cohort study in parallel groups. In addition to evaluate ..."
 
Vol 13, No 5 (2017) RIVAROXABAN OF THE BAYER COMPANY SIGNIFICANTLY (BY 24%) REDUCES THE RISK OF STROKE, CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE OR PERIPHERAL ARTERIAL DISEASE Abstract  similar documents
статья Редакционная
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"... считалось в последнее десятилетие. Распространенность ФП у пациентов с хронической болезнью почек (ХБП ..."
 
Vol 13, No 5 (2017) ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT Abstract  similar documents
S. G. Kanorskii
"... . Rivaroxaban can be given in fixed doses without routine coagulation control, and phase III studies and actual ..."
 
Vol 14, No 6 (2018) Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva, O. N. Tkacheva
"... showed that only therapy with rivaroxaban (out of three direct oral anticoagulants) compared ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... пациентам часто назначают антиагреганты. Обзор клинических и фармакоэпидемиологических исследований ..."
 
Vol 12, No 4 (2016) New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) Abstract  similar documents
Article Editorial
"... внутричерепных кровотечений на фоне терапии препаратом Ксарелто® (ривароксабан) по сравнению с варфарином у ..."
 
Vol 14, No 6 (2018) The Results of Rivaroxaban Studies COMMANDER HF and MARINER Were Published. Bayer Company Press Release . Abstract  PDF (Eng)  similar documents
artilce Editorial
 
Vol 9, No 2 (2013) ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES Abstract  similar documents
Z. M. Safiullina, S. V. Shalaev
"... inhibitors of coagulation factor Xa (rivaroxaban, apixaban), in the treatment of nonvalvular atrial ..."
 
Vol 14, No 4 (2018) Hepatotoxicity of New Oral Anticoagulants Abstract  similar documents
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin
 
Vol 9, No 6 (2013) THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY Abstract  similar documents
A. V. Shulkin, E. N. Yakusheva, N. M. Popova
"... , prasugrel) and anticoagulants (dabigatran etexilate, rivaroxaban, edoxaban) is not feasible in routine ..."
 
Vol 11, No 2 (2015) ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY Abstract  PDF (Eng)  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina
"... % of the patients received novel oral anticoagulants (dabigatran – 14%, rivaroxaban – 2%). Bleeding was fixed in 4 ..."
 
Vol 3, No 1 (2007) COMPARATIVE ANALYSIS OF SATISFACTION IN HOSPITAL TREATMENT AMONG CARDIOLOGICAL PATIENTS Abstract  similar documents
Y. G. Shvarts, E. A. Naumova, E. V. Tarasenko
"... Цель. Оценить удовлетворенность результатами лечения у пациентов кардиологического профиля и ..."
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... given rivaroxaban appeared to have higher rate of hemorrhagic events. High adherence to apixaban ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... anticoagulants such as apixaban, rivaroxaban and dabigatran. Administration of vitamin K antagonists (VKA ..."
 
Vol 15, No 1 (2019) How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice? Abstract  similar documents
M. R. Atabegashvili, E. V. Konstantinova, M. D. Muksinova, A. E. Udovichenko, A. P. Nesterov, M. O. Zheltoukhova, L. S. kyzy Muradova, M. Y. Gilarov
"... (p>0.05), age variance was 75-100 years. DM was found in 29% of all elderly patients ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... Цель.Изучить особенности вторичной профилактики сердечно-сосудистых заболеваний у пациентов разных ..."
 
Vol 12, No 1 (2016) Features of pharmacotherapy in the elderly patients. Introduction to the problem Abstract  similar documents
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz
"... Обсуждаются особенности фармакотерапии пожилых пациентов. Представлены данные по фармакокинетике и ..."
 
Vol 12, No 5 (2016) Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... Эффективность антиаритмических препаратов у пожилых аналогична таковой у более молодых пациентов ..."
 
Vol 12, No 4 (2016) Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... Применение антиаритмических препаратов I класса у пожилых пациентов ограничивают их нежелательные ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE Abstract  similar documents
G. I. Nechaeva, E. N. Loginova
"... сочетании с проведением «Школы пациента с артериальной гипертонией») с таковыми при монотерапии карведилолом ..."
 
Vol 10, No 1 (2014) SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE) Abstract  similar documents
R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. Veldhuisen van, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt
"... . Исследование ставило целью оценить безопасность и эффективность эплеренона у пациентов с высоким риском ..."
 
Vol 14, No 6 (2018) Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice Abstract  PDF (Eng)  similar documents
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova
"... was prescribed in 11 (64.7%) cases and rivaroxaban – in 6 (35.3%). Conclusion. In real clinical practice ..."
 
Vol 4, No 3 (2008) INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS) Abstract  similar documents
A. V. Kontsevaja, А. М. Kalinina, E. J. Spivak
"... in patients with ischemic heart disease (IHD). Material and methods. 100 out-patients with IHD (stable angina ..."
 
Vol 9, No 5 (2013) ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels
"... Цель. Выявить наиболее значимые факторы, формирующие отношение пациента к лечению, и факторы ..."
 
Vol 1, No 1 (2005) DRUGS AND SMOKING Abstract  similar documents
J. V. Lukina
"... эффективность и безопасность селективного и неселективного бета-адреноблокаторов у курящих и некурящих пациентов ..."
 
Vol 10, No 1 (2014) ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW Abstract  similar documents
O. N. Semenova, E. A. Naumova, Yu. G. Schwartz
"... Цель. Изучить субъективное мнение пациентов и врачей об их индивидуальном опыте приверженности ..."
 
Vol 10, No 4 (2014) THE EFFICACY OF ANTIHYPERTENSIVE THERAPY IN ELDERLY PATIENTS AND TREATMENT COMPLIANCE ANALYSIS Abstract  similar documents
V. E. Olejnikov, I. V. Eliseeva, Yu. A. Tomashevskaya, N. A. Borisova, S. S. Fadeeva
"... Цель. Изучить эффективность антигипертензивной терапии у пожилых пациентов в условиях ..."
 
Vol 13, No 2 (2017) APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... ). Доля больных с ФП в возрасте 65-85 лет достигает 70%, а средний возраст пациентов с ФП составляет 75 ..."
 
Vol 10, No 6 (2014) PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION Abstract  similar documents
N. V. Mikheeva, O. V. Reshetko, N. V. Furman
"... ретроспективное сплошное фармакоэпидемиологическое исследование. Анализировали истории болезни пациентов ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... showed the efficacy and safety of rivaroxaban and apixaban in preparation and performance of electrical ..."
 
Vol 11, No 1 (2015) ON THE SELECTION OF DRUGS DOSAGE REGIMEN Abstract  similar documents
E. N. Bochanova
"... пациента лечению, которые могут привести к необходимости уточнения режима дозирования. ..."
 
Vol 14, No 2 (2018) New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion Abstract  similar documents
A. L. Komarov, Е. S. Novikova, E. V. Guskova, Е. B. Yarovaya, A. N. Samko, E. Р. Panchenko
"... , that was demonstrated in a recently published study COMPASS. Treatment with rivaroxaban small doses in addition ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... Цель. Изучить осведомленность и мнение пациентов с фибрилляцией предсердий (ФП) о профилактике ..."
 
Vol 12, No 1 (2016) Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis Abstract  similar documents
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov
"... «венозных» пациентов увеличивается на 90-100 тыс пациентов в год [1]. Кроме того, ВТЭО стоят на третьем ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"...   of new OAC (NOAC) also appeared. In Russia, dabigatran, rivaroxaban and apixaban have been registered ..."
 
Vol 13, No 2 (2017) TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1 Abstract  similar documents
M. Yu. Gilyarov, M. O. Zheltoukhova, E. V. Konstantinova, M. D. Muksinova, L. S. Muradova, A. P. Nesterov, A. E. Udovichenko
"... .И. Пирогова г. Москвы. Материал и методы. Проанализированы 999 случаев лечения пациентов в возрасте 75 лет и ..."
 
Vol 15, No 4 (2019) Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital Abstract  similar documents
O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova
"... and conduction disorders. Chronic venous insufficiency (100%), disorders of the musculoskeletal system (100 ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... В статье рассматриваются современные европейские подходы к ведению пациентов с фибрилляцией ..."
 
Vol 12, No 4 (2016) The use of oral anticoagulants in patients with atrial fibrillation: cohort study data Abstract  similar documents
O. V. Gaisenok, A. S. Leonov
"... Цель. Изучить частоту назначения пероральных антикоагулянтов (ОАК) у пациентов с фибрилляцией ..."
 
Vol 10, No 6 (2014) THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER Abstract  similar documents
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina
"... антикоагулянтов (НОАК) у пациентов с фибрилляцией предсердий (ФП) и выявить факторы, влияющие на нее. Материал и ..."
 
Vol 14, No 1 (2018) MODERN POSSIBILITIES OF ACHIEVING TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS IN OUTPATIENT PRACTICE: THE LEADER STUDY RESULTS Abstract  similar documents
D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, O. M. Drapkina, S. A. Boytsov
"... /50, 10/50, 5/100, 10/100 mg) or hydrochlorothiazide/losartan (12.5/50, 12.5/100, 25/100 mg ..."
 
Vol 6, No 3 (2010) GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY Abstract  similar documents
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev
"... ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА ПЕРЕД ОПЕРАЦИЯМИ И ВЕДЕНИЮ ПАЦИЕНТОВ ПРИ НЕКАРДИАЛЬНЫХ ОПЕРАЦИЯХ ..."
 
Vol 6, No 4 (2010) GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY Abstract  similar documents
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev
"... ОЦЕНКЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА ПЕРЕД ОПЕРАЦИЯМИ И ВЕДЕНИЮ ПАЦИЕНТОВ ПРИ НЕКАРДИАЛЬНЫХ ОПЕРАЦИЯХ ..."
 
Vol 6, No 4 (2010) EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA Abstract  similar documents
P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev
"... of lactolycopene dissolved in 100 ml of boiled water. Levels of total cholesterol (TC), high density (HDC) and low ..."
 
Vol 9, No 1 (2013) ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM Abstract  similar documents
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok
"... . Обследовано 180 пациентов (n=180; >65 лет) с АГ 1–2 степени и вторичным соматогенным АС (по шкале MFI-20 ..."
 
Vol 11, No 3 (2015) EVALUATION OF THE REGULARITY OF ANTIHYPERTENSIVE DRUGS USAGE AS A COMPONENT OF TREATMENT ADHERENCE IN OUTPATIENTS OF A SPECIALIZED CARDIOLOGY CENTER Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S.B B. Fitilev
"... врачебных рекомендаций у различных категорий пациентов. Цель. Изучить регулярность приема ..."
 
Vol 13, No 1 (2017) LIS-3 REGISTER OF THE ACUTE CORONARY SYNDROME: WHAT HAS CHANGED IN A "PORTRAIT" OF A PATIENT AND SHORT-TERM OUTCOMES OF THE DISEASE COMPARED TO LIS-1 REGISTER Abstract  similar documents
S. Yu. Martsevich, Y. V. Semenova, N. P. Kutishenko, M. L. Ginzburg, A. V. Zagrebelnyy, A. V. Fokina, E. V. Daniels
"... умерших пациентах собиралась из историй  болезней. ЛИС-3 – проспективное исследование; данные  о выживших ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
"... рекомендациях, а также обоснованность гибкого подхода к выбору тактики ведения конкретного пациента с учетом ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... снижение затрат и увеличение продолжительности жизни пациентов по сравнению с ривароксабаном и дабигатраном ..."
 
Vol 8, No 1 (2012) ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL) Abstract  similar documents
M. A. Demidova, N. N. Kirilenko
"... into the official Standard of care (SC). Material and methods. Medical records of patients with SA (n=100) admitted ..."
 
Vol 14, No 4 (2018) Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing Abstract  similar documents
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
"... включено 100 пациентов с ФП или ТГВ, пролеченных в 2016-2017 гг. в многопрофильном стационаре г. Москвы. С ..."
 
Vol 4, No 5 (2008) EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released ..."
 
Vol 10, No 6 (2014) THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY Abstract  similar documents
A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev
"... онкологических пациентов, существующие прогностические модели не позволяют однозначно выделять тех, кому показано ..."
 
Vol 7, No 3 (2011) PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
V. A. Sulimov, A. S. Lishuta
"... Рассматривают основные принципы ведения пациентов с фибрилляцией предсердий (ФП) с учетом ..."
 
Vol 6, No 3 (2010) BLUMENTHAL SCREENING FOR CARDIOVASCULAR RISK IN ASYMPTOMATIC PATIENTS Abstract  similar documents
J. S. Berger, C. O. Jordan, D. Lloyd-Jones, R.S. Blumenthal
"... целенаправленного выбора профилактического лечения пациентов, у которых нет симптомов, но достаточно высок риск ССЗ ..."
 
Vol 2, No 3 (2006) COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS Abstract  similar documents
O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova
"... were examined. 21 patients were treated with enalapril (10-40 mgd) and 17 – with atenolol (50-100 mgd ..."
 
Vol 11, No 2 (2015) PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST Abstract  similar documents
D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii
"... доказательной базой эффективности в плане профилактики ишемических инсультов у пациентов с фибрилляцией ..."
 
Vol 4, No 1 (2008) EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE Abstract  similar documents
S. A. Smakotina, O. A. Trubnikova, O. L. Barbarash
"... into the study. All patients were given metoprolol tartrate (start dose 50-100 mg/d). Variables of 24-h BP ..."
 
Vol 12, No 6 (2016) THE ASSESSMENT OF NICORANDIL EFFECT ON THE QUALITY OF LIFE IN PATIENTS WITH STABLE ANGINA IN THE "KVAZAR" STUDY Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev
"... . All patients in the study received metoprolol tartrate (100 mg daily). Nicorandil was added (10 mg BID ..."
 
Vol 10, No 4 (2014) MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva
"... Обсуждается проблема профилактики тромбоэмболических осложнений у пациентов с фибрилляцией ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... prescriptions was revealed (at the second stage of the study acetylsalicylic acid 100 mg/day received 75 ..."
 
Vol 11, No 2 (2015) CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION Abstract  similar documents
V. N. Shishkova
"... макрососудистых осложнений у пациентов с коморбидностью. ..."
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... , and to suggest possible ways to overcome clopidogrel resistance. Material and Methods. Patients (n=100 ..."
 
Vol 3, No 5 (2007) EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
I. V. Vologdina
"... metoprolol tartrate (Egilok Retard), 50-100 mg/d additionally to standard therapy. Patients of the 2nd group ..."
 
Vol 5, No 5 (2009) ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS Abstract  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina
"... типа в условиях реальной клинической практики. Материал и методы. 200 пациентов с CД 2-го типа ..."
 
Vol 12, No 4 (2016) Organoprotective effects of serelaxin in patients with severe decompensated heart failure Abstract  similar documents
Z. D. Kobalava, S. V. Villevalde, A. E. Solov'jova, I. A. Merai
"... уменьшение застоя, а также оказывать кардио-, рено- и гепатопротективное воздействие. У пациента с ..."
 
Vol 5, No 3 (2009) RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov
"... клиническими характеристиками пациентов. Материал и методы. Проведено анонимное анкетирование 103 мужчин ..."
 
Vol 13, No 4 (2017) PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY Abstract  similar documents
O. M. Drapkina, D. U. Akasheva
"... модуляторами, применяемыми для лечения данной категории пациентов с сердечной недостаточностью. Несмотря на ..."
 
1 - 100 of 1403 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)